Alcon Inc. v. Padagis Israel Pharmaceuticals Ltd.
Original Case: 1:22-cv-01422
| Federal Circuit U.S. Court of Appeals | |
| Case #: | 0:25-cvpri-01577 |
| Type | civil private |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Case Filed: | Mar 24, 2025 |
| Last checked: Tuesday Mar 25, 2025 4:51 AM EDT |
|
Defendant - Appellant
PADAGIS ISRAEL PHARMACEUTICALS LTD.
|
Represented By
|
|
Defendant - Appellant
PADAGIS US LLC
|
Represented By
|
|
Defendant - Appellant
PADAGIS LLC
|
Represented By
|
|
Plaintiff - Appellee
ALCON INC.
|
Represented By
|
|
Plaintiff - Appellee
ALCON VISION, LLC
|
Represented By
|
|
Plaintiff - Appellee
ALCON LABORATORIES, INC.
|
Represented By
|
| Docket last updated: 03/25/2025 4:16 AM EDT |
| Monday, March 24, 2025 | ||
| 1 | 1 Appeal docketed. Received: 03/20/2025. [1077406] Entry of Appearance due 04/07/2025. Certificate of Interest is due on 04/07/2025. Docketing Statement due 04/07/2025. Appellant/Petitioner's brief is due 05/23/2025. [JSP] [Entered: 03/24/2025 12:24 PM] | |
Att: 1
4 pgs
Notice of Docketing
|
||
|
Att: 2
47 pgs
Civil Case Docketed
|
||
| 2 | 2 Note to File: The following cases are consolidated: 25-1515 Lead with 25-1577 Cross-Appeal. The parties must file all documents in the lead appeal only. [1077410] 25-1515 25-1577 [JSP] [Entered: 03/24/2025 12:27 PM] | |